Placeholder

Letter from the Editor

$30.00

Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at mwalsh@pharmavoice.com.

SKU: 430. Category: .

Product Description

In June, an unprecedented number of exhibitors and attendees convened in Washington, D.C., to attend the annual Drug Information Association (DIA) conference.
The DIA annual meeting provides a neutral forum for regulators, academics, and industry professionals to meet, network, and exchange ideas on the hot topics impacting the industry.
As an attendee of this year’s meeting, I had the pleasure of meeting Theresa Kane Musser, DIA acting president, who is also senior director of development operations at Rigel Pharmaceuticals Inc. Ms. Kane Musser stressed the importance of the DIA’s redefined mission and vision, which allow the organization to better streamline its efforts and identify strategic milestones, initiatives, and goals…

FEEDBACK